Opening book details…
About this Economics, Econometrics and Finance article
Pnd7 Cost-effectiveness Of Cladribine Compared To Natalizumab, Ocrelizumab And Alemtuzumab For The Treatment Of Patients With Highly Active Relapsing Remitting Multiple Sclerosis In Chile by Espinoza, M.A. ;Balmaceda, C. ;Rojas, R. is a Economics, Econometrics and Finance article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Economics, Econometrics and Finance.
- Author
- Espinoza, M.A. ;Balmaceda, C. ;Rojas, R.
- Publisher
- Elsevier ; Elsevier USA; Elsevier BV (ISSN 2212-1099)
- Published
- 2019
- Field
- Economics, Econometrics and Finance (Social Sciences)
More by Espinoza, M.A. ;Balmaceda, C. ;Rojas, R.
Browse all works by Espinoza, M.A. ;Balmaceda, C. ;Rojas, R.